Start your Trading & Investing Journey with us
Join our channel for Daily Free Trades with Live analysis on Youtube, Trade Setup with Important Levels, and Important Stock Market Updates
Accretion Nutraveda IPO Review - Issue Date, Price, GMP, Subscription, Allotment, Lot Size, and Details
Accretion Nutraveda Limited IPO : Key Performance Indicators, PE Ratio, EPS, ROE, ROCE & RoNW
The Company Key Performance Indicates the pre-issue EPS of ₹
71.91 and post-issue EPS of ₹
3.61 for FY25. The pre-issue P/E ratio is
1.79x,while the post-issue P/E ratio is
35.75x against the Industry P/E ratio is 45.14x The company's ROE for FY25 is
81.22% and RoNW is
48.85% The Annualised EPS is ₹
6.44x and P/E is
₹
20.02x, These metrics suggest that the IPO is Fully priced.
Key Performance Indicator
| KPI | Values |
|---|---|
| EPS Pre IPO (Rs.) | 71.91 |
| EPS Post IPO (Rs.) | 3.61 |
| Adjusted 12M EPS Post IPO (Rs.) | 6.44 |
| P/E Pre IPO | 1.79 |
| P/E Post IPO | 35.75 |
| Adjusted 12M P/E Post IPO | 20.02 |
| ROE | 81.22% |
| ROCE | 36.98% |
| P/BV | 8.76 |
| Debt/Equity | 0.72 |
| RoNW | 48.85% |
| EBITDA Margin | 22.79% |
| PAT Margin | 16.27% |